T. Logan

Detailed analysis of the basic domain of the E2F1 transcription factor indicates that it is unique among bHLH proteins.

D. Hall, A. Haas, K. L. Jordan, 1994, Oncogene.

Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.

M. Bjornsti, W. Mercer, D. Evans, 1995, Cancer research.

Three distinct elements within the murine c-myc promoter are required for transcription.

K. Moberg, D. Hall, T. Logan, 1992, Oncogene.

Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.

K. Jordan-Sciutto, G. R. Dodge, D. Hall, 1997, Experimental cell research.

Constitutive expression of the E2F1 transcription factor in fibroblasts alters G0 and S phase transit following serum stimulation.

D. Hall, K. L. Jordan, T. Logan, 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor.

D. Hall, K. L. Jordan, T. Logan, 1994, Molecular biology of the cell.

Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-κB signaling pathways and involves a novel feed-forward regulatory mechanism

V. Csizmadia, T. Logan, Xixi Yin, 2009, Molecular and Cellular Biochemistry.

Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F‐1 transcription factor

D. Hall, K. L. Jordan, T. Logan, 1997, Journal of cellular biochemistry.

Physical characteristics of a factor related to the c-myc/insulin promoter binding protein ZF87/Pur-1.

D. Hall, T. Logan, J. Pyrc, 1993, Biochemical and biophysical research communications.